国家早期预警评分能准确区分肝病患者发生严重不良事件的风险
该研究基于英格兰南部一家大型急症医院2010年1月1日至2014年10月31日连续收治的16岁及以上患者实时生命体征数据,按国际疾病分类第10版编码将患者分为原发性肝病、继发性肝病和无肝病,比较国家早期预警评分(NEWS)与34种其他早期预警评分对24小时内死亡、心脏骤停或非计划入住重症监护室的区分能力。结果显示NEWS对原发性肝病、非原发性肝病和无肝病患者的AUROC分别为0.873(95%CI,0.860-0.886)、0.898(95%CI,0.891-0.905)和0.879(95%CI,0.877-0.881),对酒精相关肝病患者的AUROC为0.927(95%CI,0.912-0.941),且区分能力高于其他早期预警评分系统。
要点
- NEWS对原发性肝病、非原发性肝病和无肝病患者24小时内严重不良事件的AUROC分别为0.873、0.898和0.879。
- NEWS对酒精相关肝病患者的AUROC为0.927(95%CI,0.912-0.941)。
- NEWS对肝病患者的区分能力高于其他早期预警评分系统。
核心结论
- NEWS能准确区分多种肝相关诊断患者24小时内死亡、入住重症监护室或心脏骤停的风险。
- NEWS的广泛使用为识别需要早期评估和干预的肝病患者提供了现成、易用的选择,无需修改参数、权重或升级标准。
研究设计与样本
- 研究收集了2010年1月1日至2014年10月31日期间英格兰南部一家大型急症医院连续收治的16岁及以上患者的实时生命体征记录。
- 使用国际疾病分类第10版编码将患者分为原发性肝病、继发性肝病或无肝病。
- 对肝病患者建立两个分析组:第一组基于临床分组(如急性或慢性、酒精诱发或与门静脉高压相关),第二组基于肝相关医院级死亡指标诊断的汇总。
- 对每个分析组,使用受试者工作特征曲线下面积(AUROC)和早期预警评分效率曲线分析,比较NEWS与34种其他早期预警评分对24小时死亡率、心脏骤停或非计划入住重症监护室的区分能力。
主要发现
- NEWS识别原发性肝病、非原发性肝病和无肝病患者的AUROC分别为0.873(95%CI,0.860-0.886)、0.898(95%CI,0.891-0.905)和0.879(95%CI,0.877-0.881)。
- 所有临床亚组均获得高AUROC值;NEWS识别酒精相关肝病患者的AUROC为0.927(95%CI,0.912-0.941)。
- NEWS识别肝病患者的AUROC值高于其他早期预警评分系统。
关键数值与推荐
- NEWS对原发性肝病、非原发性肝病和无肝病患者24小时内死亡、心脏骤停或非计划入住重症监护室的AUROC分别为0.873(95%CI,0.860-0.886)、0.898(95%CI,0.891-0.905)和0.879(95%CI,0.877-0.881)。
- NEWS对酒精相关肝病患者的AUROC为0.927(95%CI,0.912-0.941)。
- NEWS对肝病患者的AUROC值高于其他早期预警评分系统。
临床怎么用
- NEWS的广泛使用为识别需要早期评估和干预的肝病患者提供了现成、易用的选择,无需修改参数、权重或升级标准。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The National Early Warning Score (NEWS) is used to identify deteriorating adult hospital inpatients. However, it includes physiological parameters frequently altered in patients with cirrhosis. We aimed to assess the performance of the NEWS in acute and chronic liver diseases. METHODS: We collected vital signs, recorded in real time, from completed consecutive admissions of patients 16 years or older to a large acute-care hospital in Southern England, from January 1, 2010, through October 31, 2014. Using International Classification of Diseases, 10th revision, codes, we categorized patients as having primary liver disease, secondary liver disease, or none. For patients with liver disease, 2 analysis groups were developed: the first was based on clinical group (such as acute or chronic, alcohol-induced, or associated with portal hypertension), and the second was based on a summary of liver-related, hospital-level mortality indicator diagnoses. For each, we compared the abilities of the NEWS and 34 other early warning scores to discriminate 24-hour mortality, cardiac arrest, or unanticipated admission to the intensive care unit using the area under the receiver operating characteristic (AUROC) curve and early warning score efficiency curve analyses. RESULTS: The NEWS identified patients with primary, nonprimary, and no diagnoses of liver disease with AUROC values of 0.873 (95% CI, 0.860-0.886), 0.898 (95% CI, 0.891-0.905), and 0.879 (95% CI, 0.877-0.881), respectively. High AUROC values were also obtained for all clinical subgroups; the NEWS identified patients with alcohol-related liver disease with an AUROC value of 0.927 (95% CI, 0.912-0.941). The NEWS identified patients with liver diseases with higher AUROC values than other early warning scoring systems. CONCLUSIONS: The NEWS accurately discriminates patients at risk of death, admission to the intensive care unit, or cardiac arrest within a 24-hour period for a range of liver-related diagnoses. Its widespread use provides a ready-made, easy-to-use option for identifying patients with liver disease who require early assessment and intervention, without the need to modify parameters, weightings, or escalation criteria.
引用
- Hydes TJ, Meredith P, Schmidt PE, et al. National Early Warning Score Accurately Discriminates the Risk of Serious Adverse Events in Patients With Liver Disease. Clin Gastroenterol Hepatol. 2017. PMID: 29277622. doi:10.1016/j.cgh.2017.12.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。